FDA finalizes guidance on transferring 510(k) ownership
The US Food and Drug Administration (FDA) has finalized a guidance that outlines the responsibilities of owners of 510(k) clearances when products are sold or transferred between companies. The final document significantly shortens certain sections, while adding new questions and answers.
comments(0)
5-min edit window · permanent after that